DV Biomed Co., Ltd. (TPEX:6539)
Taiwan · Delayed Price · Currency is TWD 51.90
-1.00 (-1.89%)
Mar 26, 2026, 9:48 AM CST
DV Biomed Market Cap
DV Biomed has a market cap or net worth of 1.26 billion as of March 26, 2026. Its market cap has decreased by -0.58% in one year.
Market Cap
1.26B
Enterprise Value
994.53M
Revenue
712.61M
Ranking
n/a
PE Ratio
25.16
Stock Price
51.90
Market Cap Chart
Since October 15, 2015, DV Biomed's market cap has decreased from 5.01B to 1.26B, a decrease of -74.76%. That is a compound annual growth rate of -12.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 1.26B | -12.03% |
| Dec 31, 2025 | 1.44B | 11.93% |
| Dec 30, 2024 | 1.28B | -55.96% |
| Dec 29, 2023 | 2.91B | -11.33% |
| Dec 30, 2022 | 3.29B | -5.52% |
| Dec 30, 2021 | 3.48B | -17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 1.97B |
| Golden Biotechnology | 1.95B |
| Tien Liang BioTech | 1.62B |
| GeneFerm Biotechnology | 1.56B |
| InnoPharmax | 1.55B |
| Winston Medical Supply | 1.30B |
| Excelsior Biopharma | 1.23B |
| Anxo Pharmaceutical | 1.09B |